Expertise in
20
conditions

Dr. Joseph M. Ojile

Internal Medicine
Caduceus Corporation
11200 Tesson Ferry Rd, Suite 100, 
St. Louis, MO 
Accepting New Patients
Offers Telehealth
Expertise in
20
conditions
Caduceus Corporation
11200 Tesson Ferry Rd, Suite 100, 
St. Louis, MO 

Overview

Joseph Ojile is a primary care provider, practicing in Internal Medicine in St. Louis, Missouri.

Dr. Ojile is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Restless Legs Syndrome, Excessive Daytime Sleepiness, Drowsiness, and Central Sleep Apnea.

He is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 10 clinical trials. Dr. Ojile is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in MO

Hospital Affiliations

Mercy Hospital St Louis
Mercy Hospital South
Mercy Hospital Jefferson

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Caduceus Corporation
11200 Tesson Ferry Rd, Suite 100, St. Louis, MO 63123

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
Clinical Performance of the AFGen1 Device Over a 7-day Period
Clinical Performance of the AFGen1 Device Over a 7-day Period
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Device
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Drug
Study Drugs: Atomoxetine, AD313
Study Phase: Phase 1/Phase 2
Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis
Independent Validation Study of Nighttime Scratching Quantification With Actigraphy in Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: March 09, 2023
Intervention Type: Device
Diagnostic Validation of the DreamKit Device Against Polysomnography
Diagnostic Validation of the DreamKit Device Against Polysomnography
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Device
Study Phase: Not Applicable
An Open-label Randomized Controlled Trial Assessing the Efficacy of Intraoral Neuromuscular Electrical Stimulation for Treatment of Mild Obstructive Sleep Apnea: The OREM Trial
An Open-label Randomized Controlled Trial Assessing the Efficacy of Intraoral Neuromuscular Electrical Stimulation for Treatment of Mild Obstructive Sleep Apnea: The OREM Trial
Enrollment Status: Unknown
Publish Date: December 02, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)
Enrollment Status: Completed
Publish Date: September 21, 2018
Intervention Type: Other
View 9 Less Clinical Trials

21 Total Publications

Acute effects of tonic motor activation (TOMAC) on sleep in adults with medication-refractory restless legs syndrome.
Acute effects of tonic motor activation (TOMAC) on sleep in adults with medication-refractory restless legs syndrome.
Journal: Sleep advances : a journal of the Sleep Research Society
Published: May 05, 2026
Similar Doctors
Expertise in
28
conditions
Dr. Michael P. Whyte
Internal Medicine
Expertise in
28
conditions
Dr. Michael P. Whyte
Internal Medicine

Office

4921 Parkview Pl Ste 5C, 
Saint Louis, MO 
 (7.0 miles away)
314-454-7775
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Whyte is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Whyte is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hypophosphatasia (HPP), Juvenile Paget's Disease, Rickets, Osteopetrosis, and Leg or Foot Amputation. Dr. Whyte is currently accepting new patients.

Expertise in
13
conditions
Dr. John C. Morris
Internal Medicine
Expertise in
13
conditions
Dr. John C. Morris
Internal Medicine

Office

4488 Forest Park Ave Ste 160, 
Saint Louis, MO 
 (7.8 miles away)
314-286-1967
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Morris is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Morris is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Primary Amyloidosis, Thyroidectomy, and Vertebroplasty. Dr. Morris is currently accepting new patients.

Expertise in
127
conditions
Dr. Morey A. Blinder
Internal Medicine
Expertise in
127
conditions
Dr. Morey A. Blinder
Internal Medicine

Office

4921 Parkview Pl Ste 7B, 
Saint Louis, MO 
 (7.0 miles away)
314-362-7216
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Morey Blinder is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Blinder is highly rated in 127 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Anaplastic Large Cell Lymphoma, Acute Myeloblastic Leukemia with Maturation, and Thrombectomy. Dr. Blinder is currently accepting new patients.

Frequently Asked Questions about Dr. Joseph M. Ojile

How do I make an appointment with Dr. Joseph M. Ojile?

You can book an appointment with Dr. Joseph M. Ojile by calling their office at 314-849-1500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph M. Ojile a top-rated expert for Restless Legs Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph M. Ojile is classified as an Elite expert for Restless Legs Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph M. Ojile specialize in?

While Dr. Joseph M. Ojile is a Internal Medicine, they have specific expertise in Restless Legs Syndrome, Excessive Daytime Sleepiness, and Drowsiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Joseph M. Ojile participate in research or clinical trials?

Yes. Dr. Joseph M. Ojile has published 21 articles and abstracts on conditions like Restless Legs Syndrome. You can view a list of Dr. Joseph M. Ojile's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph M. Ojile accept my insurance?

Dr. Joseph M. Ojile accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-849-1500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ojile's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 65 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile